{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:18:17Z","timestamp":1761862697806,"version":"build-2065373602"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2019-1772 PICT-2021-0409"],"award-info":[{"award-number":["PICT-2019-1772 PICT-2021-0409"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    Vanishing white matter (VWM) is a rare autosomal recessive leukodystrophy associated with pathogenic variants in any of the five genes (\n                    <jats:italic>EIF2B1-5<\/jats:italic>\n                    ) that encode subunits of the eukaryotic translation initiation factor 2B (eIF2B). Here, we present a case of a 26-year-old female patient from a non-consanguineous Amerindian Bolivian family, with clinical and neuroimaging findings suggestive of early-onset VWM, characterized by slowly progressive neurological deterioration in the absence of ovarian disorder. Whole-exome sequencing revealed a novel pair of compound heterozygous variants in the\n                    <jats:italic>EIF2B5<\/jats:italic>\n                    gene, confirming the diagnosis of leukodystrophy with VWM and bringing closure to a nearly 20-year diagnostic odyssey. The identified c.318A&amp;gt;T (p.Leu106Phe) and c.1688G&amp;gt;A (p.Arg563Gln) in the\n                    <jats:italic>EIF2B5<\/jats:italic>\n                    gene were classified as pathogenic and likely pathogenic, respectively, according to the American College of Medical Genetics and Genomics. Complementary Sanger sequencing revealed that the variants co-segregated with the phenotype in the pedigree, providing strong evidence of autosomal recessive inheritance of the disease, and enabling the molecular diagnosis of two asymptomatic sisters with white matter lesions on neuroimaging. This case underscores the heterogeneous nature of VWM, and emphasizes the relevance of integrating a comprehensive clinical evaluation, brain magnetic resonance imaging, and genetic studies in the diagnosis of leukodystrophies.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2025.1688885","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:10:09Z","timestamp":1761862209000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cCase report\u201d: Whole-exome sequencing reveals compound heterozygous variants in the EIF2B5 gene in a familial case of vanishing white matter"],"prefix":"10.3389","volume":"16","author":[{"given":"Sof\u00eda","family":"Savy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco A.","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola L.","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Lar\u00f3vere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silene M.","family":"Silvera-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo H.","family":"Carro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Guelbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.clineuro.2018.06.023","article-title":"Vanishing white matter disease with a novel EIF2B5 mutation: a 10-year follow-up","volume":"171","author":"Bektas","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/thy.2021.0344","article-title":"An intramolecular ionic interaction linking defective sodium\/iodide symporter transport to the plasma membrane and dyshormonogenic congenital hypothyroidism","volume":"32","author":"Bernal Barquero","year":"2022","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1465176","DOI":"10.3389\/fendo.2024.1465176","article-title":"Functional characterization of novel compound heterozygous missense SLC5A5 gene variants causing congenital dyshormonogenic hypothyroidism","volume":"15","author":"Carro","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ahg.12345","article-title":"Argentinian clinical genomics in a leukodystrophies and genetic leukoencephalopathies cohort: diagnostic yield in our first 9 years","volume":"84","author":"Cohen","year":"2020","journal-title":"Ann. Hum. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.crad.2023.02.011","article-title":"An approach to reporting paediatric leukoencephalopathy and leukodystrophies","volume":"78","author":"Davies","year":"2023","journal-title":"Clin. Radiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"729777","DOI":"10.3389\/fgene.2021.729777","article-title":"Correlation between genotype and age of onset in leukoencephalopathy with vanishing white matter","volume":"12","author":"Deng","year":"2021","journal-title":"Front. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"868891","DOI":"10.3389\/fendo.2022.868891","article-title":"Silent but not harmless: a synonymous SLC5A5 gene variant leading to dyshormonogenic congenital hypothyroidism","volume":"13","author":"Geysels","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ana.25287","article-title":"Natural history of vanishing white matter","volume":"84","author":"Hamilton","year":"2018","journal-title":"Ann. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e8318","DOI":"10.1371\/journal.pone.0008318","article-title":"Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders","volume":"4","author":"Horzinski","year":"2009","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/practneurol-2016-001382","article-title":"Ovarioleukodystrophy due to EIF2B5 mutations","volume":"16","author":"Ibitoye","year":"2016","journal-title":"Pract. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"105287","DOI":"10.1016\/j.jbc.2023.105287","article-title":"Protection of eIF2B from inhibitory phosphorylated eIF2: a viral strategy to maintain mRNA translation during the PKR-triggered integrated stress response","volume":"299","author":"Ito","year":"2023","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"813032","DOI":"10.3389\/fneur.2022.813032","article-title":"Association between late-onset leukoencephalopathy with vanishing white matter and compound heterozygous EIF2B5 gene mutations: a case report and review of the literature","volume":"13","author":"Kong","year":"2022","journal-title":"Front. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/brain\/awp171","article-title":"Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases","volume":"132","author":"Labauge","year":"2009","journal-title":"Brain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng764","article-title":"Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter","volume":"29","author":"Leegwater","year":"2001","journal-title":"Nat. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1089\/thy.2019.0046","article-title":"Novel sodium\/iodide symporter compound heterozygous pathogenic variants causing dyshormonogenic congenital hypothyroidism","volume":"29","author":"Martin","year":"2019","journal-title":"Thyroid"},{"key":"B16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1042\/BST0360658","article-title":"Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation","volume":"36","author":"Mohammad-Qureshi","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"B17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ymgme.2014.12.434","article-title":"A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies","volume":"114","author":"Parikh","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1128\/MCB.24.6.2352-2363.2004","article-title":"Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity","volume":"24","author":"Richardson","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1002\/mgg3.1593","article-title":"Vanishing white matter: eukaryotic initiation factor 2B model and the impact of missense mutations","volume":"9","author":"Slynko","year":"2021","journal-title":"Mol. Genet. Genomic Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.braindev.2014.10.002","article-title":"A Japanese girl with an early-infantile onset Vanishing white matter disease resembling Cree leukoencephalopathy","volume":"37","author":"Takano","year":"2015","journal-title":"Brain Dev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/humu.24088","article-title":"Fitting a naturally scaled point system to the ACMG\/AMP variant classification guidelines","volume":"41","author":"Tavtigian","year":"2020","journal-title":"Hum. Mutat."},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4137\/JCNSD.S13540","article-title":"Vanishing white matter disease in a spanish population","volume":"6","author":"Turon-Vinas","year":"2014","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1212\/NXG.0000000000000657","article-title":"Therapy trial design in vanishing white matter: an expert consortium opinion","volume":"8","author":"van der Knaap","year":"2022","journal-title":"Neurol. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymgme.2015.01.006","article-title":"Case definition and classification of leukodystrophies and leukoencephalopathies","volume":"114","author":"Vanderver","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/ana.24650","article-title":"Whole exome sequencing in patients with white matter abnormalities","volume":"79","author":"Vanderver","year":"2016","journal-title":"Ann. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"35936","DOI":"10.1038\/srep35936","article-title":"The use of targeted genomic capture and massively parallel sequencing in diagnosis of Chinese leukoencephalopathies","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e42940","DOI":"10.7554\/eLife.42940","article-title":"eIF2B activator prevents neurological defects caused by a chronic integrated stress response","volume":"8","author":"Wong","year":"2019","journal-title":"Elife"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1688885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:10:10Z","timestamp":1761862210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1688885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":29,"alternative-id":["10.3389\/fgene.2025.1688885"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1688885","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"1688885"}}